This Article  • References  • Full text PDF  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Citation map  • Citing articles on HighWire  • Contact me when this article is cited  Related Content  • Similar articles in this journal  Social Bookmarking   What's this?

Daniel R. Budman, MD; Alfred D. Steinberg, MD

Arch Intern Med. 1976;136(9):1003-1007.

Abstract
A retrospective analysis of 235 patients at the National Institutes of Health who met at least five criteria for systemic lupus erythematosus (SLE) indicated that 45% were hypertensive. Approximately two thirds of these hypertensive patients had creatinine clearances of more than 60 ml/min and nonnephrotic range proteinuria. Only 16% of normotensive patients had creatinine clearances of less than 60 ml/min. A subgroup of 36 patients with SLE and with biopsy-proved diffuse renal disease were studied. For these patients, the presence of hypertension could not be correlated with the degree of proteinuria or hematuria, with the level of serum complement, or with the presence of casts, focal necrosis, crescent formation, or interstitial inflammation. Hypertensive patients had a median age of 24.5 years; the majority had creatinine clearances of more than 60 ml/min. In SLE, hypertension is not necessarily associated with advanced renal disease, and high blood pressure may occur relatively early in the course of the disease.

(Arch Intern Med 136:1003-1007, 1976)

Author Affiliations
From the Arthritis and Rheumatism Branch, National Institute of Arthritis, Metabolism, and Digestive Diseases.

Footnotes
Received for publication Nov 14, 1975; accepted Feb 10, 1976.

Reprint requests to Arthritis and Rheumatism Branch, National Institute of Arthritis, Metabolism, and Digestive Diseases, National Institutes of Health, Bethesda, MD 20014 (Dr Steinberg).

CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter     What's this?

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Young Investigator Award Lecture of the APS Water and Electrolyte Homeostasis Section, 2008: The pathophysiology of hypertension in systemic lupus erythematosus
Ryan
Am. J. Physiol. Regul. Integr. Comp. Physiol. 2009;296:R1258-R1267.
ABSTRACT | FULL TEXT  

Hypertension and impaired vascular function in a female mouse model of systemic lupus erythematosus
Ryan and McLemore
Am. J. Physiol. Regul. Integr. Comp. Physiol. 2007;292:R736-R742.
ABSTRACT | FULL TEXT  

Clinical Prognostic Factors in Lupus Nephritis: The Importance of Hypertension and Smoking
Ward and Studenski
Arch Intern Med 1992;152:2082-2088.
ABSTRACT  

Nifedipine in the Treatment of Hypertension in Systemic Lupus Erythematosus
Bursztyn et al.
ANGIOLOGY 1987;38:359-362.
ABSTRACT  

Controlled Studies of Oral Immunosuppressive Drugs in Lupus Nephritis: A Long-Term Follow-Up
CARETTE et al.
ANN INTERN MED 1983;99:1-8.
ABSTRACT  

Alternative Modes of Cyclophosphamide and Azathioprine Therapy in Lupus Nephritis
DINANT et al.
ANN INTERN MED 1982;96:728-736.
ABSTRACT